Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Challen, Grant A  [Clear All Filters]
2022
SanMiguel JM, Eudy E, Loberg MA, Young KA, Mistry JJ, Mujica KD, Schwartz LS, Stearns TM, Challen GA, Trowbridge JJ. Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness Versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis. Cancer Discov. 2022.
Kong T, Laranjeira ABA, Yang K, Fisher DAC, Yu LY, De La Frégonnière LPoittevin, Wang AZ, Ruzinova MB, Fowles JS, Fulbright MC, et al. DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression. Nat Cancer. 2022.
Wiley B, Parsons TM, Burkart S, Young AL, Erlandson KM, Tassiopoulos KK, Wu K, Gurnett C, Presti RM, Bolton KL, et al. The Impact of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV. Exp Hematol. 2022.
2021
Hormaechea-Agulla D, Matatall KA, Le DT, Kain B, Long X, Kus P, Jaksik R, Challen GA, Kimmel M, King KY. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling. Cell Stem Cell. 2021.
2018
Celik H, Koh WKyun, Kramer AC, Ostrander EL, Mallaney C, Fisher DAC, Xiang J, Wilson WC, Martens A, Kothari A, et al. JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells. Cancer Cell. 2018;34(5):741-756.e8.
2016
Celik H, Kramer A, Challen GA. DNA methylation in normal and malignant hematopoiesis. Int J Hematol. 2016.
Yang L, Rodriguez B, Mayle A, Park HJung, Lin X, Luo M, Jeong M, Curry CV, Kim S-B, Ruau D, et al. DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias. Cancer Cell. 2016;29(6):922-934.